All news
Neutral impactCompany

Sun Pharma Advanced Research Company Limited — Rescission/termination(s)

NSE 25 Jun·25 Jun 2026, 1:02 pm

Sun Pharma Advanced Research Company Limited has informed the Exchange about Termination of License Agreement with CMS Bridging DMCC

Stocks in this story

Dmcc Speciality Chemicals251.25 3.25%

Key takeaways

  • Concerns Dmcc Speciality Chemicals (DMCC).
  • Category: Company.

Why it matters

A routine update for Dmcc Speciality Chemicals. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.